Hazard ratio (HR) of forearm or hip fractures according to self‐reported psoriasis in the third Nord‐Trøndelag Health Study (HUNT3) population of Norway (n = 46 363)
| HUNT3 | HR adjusted for age | Additional adjustment for education, smoking, systemic steroid use | Additional adjustment for BMI | ||
| Fractures | Person‐time | ||||
| Overall (n)a | |||||
| No psoriasis | 1118 | 225 989 | 1·00 (ref.) | 1·00 (ref.) | 1·00 (ref.) |
| Psoriasis | 73 | 13 896 | 1·03 (0·82–1·31) | 1·00 (0·79–1·27) | 1·04 (0·82–1·31) |
| Women (n) | |||||
| No psoriasis | 816 | 121 555 | 1·00 (ref.) | 1·00 (ref.) | 1·00 (ref.) |
| Psoriasis | 62 | 7093 | 1·24 (0·95–1·60) | 1·20 (0·92–1·55) | 1·24 (0·96–1·61) |
| Men (n) | |||||
| No psoriasis | 302 | 104 433 | 1·00 (ref.) | 1·00 (ref.) | 1·00 (ref.) |
| Psoriasis | 11 | 6803 | 0·55 (0·30–1·00) | 0·54 (0·30–1·00) | 0·56 (0·30–1·02) |
| HUNT3 | HR adjusted for age | Additional adjustment for education, smoking, systemic steroid use | Additional adjustment for BMI | ||
| Fractures | Person‐time | ||||
| Overall (n)a | |||||
| No psoriasis | 1118 | 225 989 | 1·00 (ref.) | 1·00 (ref.) | 1·00 (ref.) |
| Psoriasis | 73 | 13 896 | 1·03 (0·82–1·31) | 1·00 (0·79–1·27) | 1·04 (0·82–1·31) |
| Women (n) | |||||
| No psoriasis | 816 | 121 555 | 1·00 (ref.) | 1·00 (ref.) | 1·00 (ref.) |
| Psoriasis | 62 | 7093 | 1·24 (0·95–1·60) | 1·20 (0·92–1·55) | 1·24 (0·96–1·61) |
| Men (n) | |||||
| No psoriasis | 302 | 104 433 | 1·00 (ref.) | 1·00 (ref.) | 1·00 (ref.) |
| Psoriasis | 11 | 6803 | 0·55 (0·30–1·00) | 0·54 (0·30–1·00) | 0·56 (0·30–1·02) |
Data are HR (95% confidence interval) unless otherwise indicated. aAdjusted for sex.
Hazard ratio (HR) of forearm or hip fractures according to self‐reported psoriasis in the third Nord‐Trøndelag Health Study (HUNT3) population of Norway (n = 46 363)
| HUNT3 | HR adjusted for age | Additional adjustment for education, smoking, systemic steroid use | Additional adjustment for BMI | ||
| Fractures | Person‐time | ||||
| Overall (n)a | |||||
| No psoriasis | 1118 | 225 989 | 1·00 (ref.) | 1·00 (ref.) | 1·00 (ref.) |
| Psoriasis | 73 | 13 896 | 1·03 (0·82–1·31) | 1·00 (0·79–1·27) | 1·04 (0·82–1·31) |
| Women (n) | |||||
| No psoriasis | 816 | 121 555 | 1·00 (ref.) | 1·00 (ref.) | 1·00 (ref.) |
| Psoriasis | 62 | 7093 | 1·24 (0·95–1·60) | 1·20 (0·92–1·55) | 1·24 (0·96–1·61) |
| Men (n) | |||||
| No psoriasis | 302 | 104 433 | 1·00 (ref.) | 1·00 (ref.) | 1·00 (ref.) |
| Psoriasis | 11 | 6803 | 0·55 (0·30–1·00) | 0·54 (0·30–1·00) | 0·56 (0·30–1·02) |
| HUNT3 | HR adjusted for age | Additional adjustment for education, smoking, systemic steroid use | Additional adjustment for BMI | ||
| Fractures | Person‐time | ||||
| Overall (n)a | |||||
| No psoriasis | 1118 | 225 989 | 1·00 (ref.) | 1·00 (ref.) | 1·00 (ref.) |
| Psoriasis | 73 | 13 896 | 1·03 (0·82–1·31) | 1·00 (0·79–1·27) | 1·04 (0·82–1·31) |
| Women (n) | |||||
| No psoriasis | 816 | 121 555 | 1·00 (ref.) | 1·00 (ref.) | 1·00 (ref.) |
| Psoriasis | 62 | 7093 | 1·24 (0·95–1·60) | 1·20 (0·92–1·55) | 1·24 (0·96–1·61) |
| Men (n) | |||||
| No psoriasis | 302 | 104 433 | 1·00 (ref.) | 1·00 (ref.) | 1·00 (ref.) |
| Psoriasis | 11 | 6803 | 0·55 (0·30–1·00) | 0·54 (0·30–1·00) | 0·56 (0·30–1·02) |
Data are HR (95% confidence interval) unless otherwise indicated. aAdjusted for sex.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
